Medicine and Dentistry
Prostate Cancer
100%
Malignant Neoplasm
26%
Prostatectomy
25%
Biochemical Recurrence
15%
Breast Cancer
14%
Diseases
13%
Quality of Life
13%
Prostate Specific Antigen
12%
Overall Survival
11%
Biopsy Technique
11%
Social Determinants of Health
11%
Neoplasm
10%
Metastatic Carcinoma
10%
Proportional Hazards Model
9%
Meta-Analysis
8%
Hazard Ratio
8%
Cardiovascular System
7%
External Beam Radiotherapy
7%
Gleason Score
7%
Biological Marker
7%
Recurrent Disease
7%
Tumor
7%
Health Care Cost
7%
Cardiovascular Disease
6%
Odds Ratio
6%
Health Care
6%
Radiation Therapy
6%
Cancer Mortality
6%
Racial Disparity
5%
Androgen Deprivation Therapy
5%
Androgen
5%
Gene Expression
5%
Cancer Growth
5%
Nursing Home
5%
Keyphrases
Prostate Cancer
66%
Radical Prostatectomy
25%
Biochemical Recurrence
13%
Prostate Cancer Patients
11%
Confidence Interval
11%
Health-related Quality of Life
11%
Low-risk Prostate Cancer
11%
Overall Survival
11%
Prostate Cancer Risk
11%
Breast Cancer
10%
African American
9%
External Beam Radiotherapy
9%
Intermediate-risk Prostate Cancer
8%
Smoking Cessation
8%
African Ancestry
8%
Caucasian American
7%
Quality of Life Outcomes
7%
Genomic Prostate Score
7%
Prostate Cancer Progression
7%
Cardiovascular Outcomes
7%
Prostate-specific Antigen
7%
Active Surveillance
7%
Social Determinants of Health (SDoH)
6%
Racial Disparities
6%
Polygenic Risk Score
6%
Racially Diverse
6%
Androgen Deprivation Therapy
6%
Quit Attempts
6%
Prostate Cancer Outcomes
6%
Media Campaign
5%
Metastasis
5%
Quality of Life
5%
Gleason Score
5%
Meta-analysis
5%
Non-Hispanic White
5%
Radiation Therapy
5%
Multivariable
5%
Alkaline Phosphatase
5%
Odds Ratio
5%
High Risk
5%
Smokers
5%
Breast Cancer Treatment
5%
Disease Progression
5%
Bone Metastasis
5%
Patients with Prostate Cancer
5%